We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0158 | -2.10106382979 | 0.752 | 0.7756 | 0.67 | 281802 | 0.73000715 | CS |
4 | -3.2838 | -81.6865671642 | 4.02 | 4.9979 | 0.67 | 562728 | 1.54754339 | CS |
12 | -5.9386 | -88.9704560436 | 6.6748 | 10.8 | 0.67 | 484659 | 4.57840499 | CS |
26 | -13.6958 | -94.8988359202 | 14.432 | 15.1448 | 0.67 | 457270 | 6.67523399 | CS |
52 | -80.6638 | -99.0955773956 | 81.4 | 91.96 | 0.67 | 382348 | 15.48489548 | CS |
156 | -1134.0238 | -99.9351228454 | 1134.76 | 1397.44 | 0.67 | 530177 | 431.17227555 | CS |
260 | -33.7686 | -97.8663838075 | 34.5048 | 2640 | 0.67 | 554733 | 429.22102163 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions